A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

BACKGROUND: Recurrent vulvovaginal candidiasis (RVVC) is a problematic form of mucosal Candida infection, characterized by repeated episodes per year. Candida albicans is the most common cause of RVVC. Currently, there are no immunotherapeutic treatments for RVVC. METHODS: This exploratory randomize...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Infect Dis
Päätekijät: Edwards, John E, Schwartz, Michael M, Schmidt, Clint S, Sobel, Jack D, Nyirjesy, Paul, Schodel, Florian, Marchus, Erica, Lizakowski, Mary, DeMontigny, Elizabeth A, Hoeg, Jesse, Holmberg, Tuomas, Cooke, M Timothy, Hoover, Keila, Edwards, Lance, Jacobs, Mark, Sussman, Steven, Augenbraun, Michael, Drusano, Michael, Yeaman, Michael R, Ibrahim, Ashraf S, Filler, Scott G, Hennessey, John P
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Articles and Commentaries
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5982716/
https://ncbi.nlm.nih.gov/pubmed/29697768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy185
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia